Recombinant DNA Fermenter, circa 1977

Fermenters like this one used genetically-manipulated bacteria to produce the first human insulin in 1977 and the first human growth factor in 1979. Credit: © SSPL / Science Museum" />Fermenters like this one used genetically-manipulated bacteria to produce the first human insulin in 1977 and the first human growth factor in 1979. Credit: © SSPL / Science Museum In 1972, Uni

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In 1972, University of California, San Francisco, biochemist Herbert Boyer met Stanford University geneticist Stanley Norman Cohen at a meeting in Hawaii. The two then kicked off a collaboration that eventually led to the creation of the first recombinant DNA, a landmark that ushered in the era of modern biotechnology. By combining Cohen's expertise with bacterial plasmids and Boyer's know-how about restriction enzymes, the two found that they could use bacteria as tiny factories for producing many human proteins. Boyer went on to found Genentech in 1976.

In order to produce the proteins in mass quantities, the fledgling biotech company needed a way to grow transgenic bacteria on an industrial scale. To do that, they turned to the ancient art of fermentation. People had made wine, bread, and beer for thousands of years, yet it wasn't until World War I when tons of acetone and other explosive ingredients were needed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Tia Ghose

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours